January 2, 2023 — IBA, a world leader in particle accelerator technology, today confirms that it has signed a contract with the Spanish Ministry of Health to install ten proton therapy systems across Spain as part of a significant public tender.

January 2, 2023 — The federal agency that oversees the administration of nuclear medicine has announced that it will reconsider its policy affecting extravasation, in a 

January 2, 2023 — Detection Technology, a global leader in X-ray detector solutions, announced X-ACE 16 HD (high-definition) as an addition to its unique standard medical CT (computed tomography) detector offering.

The ITN team wishes you a happy and healthy New Year!

December 30, 2022 — KA Imaging’s dual-energy technology (branded as SpectralDR) has been shown to improve reading efficiency in non-radiological environments.

December 30, 2022 — A milestone was reached in radiation therapy last week as the first patients completed their full course of radiation therapy treatment with Elekta (EKTA-B.ST) Unity MR-Linac using Comprehensive Motion Management (CMM) with True Tracking and automatic gating functionalities.

December 30, 2022 — Carestream Health announced new innovations in its long-length imaging digital radiography (DR) detector that are aimed at improving patient comfort, productivity and efficiency.

December 29, 2022 — NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced the first installation of its SmartMSU with OmniTom Elite – a specialized ambulance that is equipped with a small computed tomography (CT) scanner for head imaging – in the Asia-Pacific region.

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Alexander Shestopalov, MD, Vascular and Interventional Radiologist to its clinic serving the greater Houston area at 

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now